PDE3/PDE4 inhibitors (Leiden/Amsterdam Center for Drug Research/Altana)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NamePDE3/PDE4 inhibitors (Leiden/Amsterdam Center for Drug Research/Altana)
Drug Alias NamePDE3/PDE4 inhibitors (Leiden/Amsterdam Center for Drug Research/Byk Gulden)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodieterase 4 inhibitorsPhosphodiesterase 3 inhibitors
TargetsPhosphodiesterase 3Phosphodieterase 4
Therapy Area/IndicationsAsthmaArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlandsGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLeiden/Amsterdam Center for Drug Research
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLeiden/Amsterdam Center for Drug ResearchTakeda GmbH
Active IndicationsN/A
Inactive IndicationsAsthmaArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A